Terrell Davis, TD, has been a mental health advocate ever since going public about his own mental health challenges. That's ...

Neurocrine Biosciences (NBIX) recently caught attention with the publication of a comprehensive peer-reviewed review that brings together more than ten years of research on its VMAT2 inhibitors for ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 9:30 AM ESTCompany ParticipantsMatthew Abernethy ...

Thank you, Todd. From a commercial perspective, for INGREZZA, the recent investments to expand our sales force and improve ...

Calling him a “tremendous” health advocate, DeMyers adds that leveraging Davis to get the word out about TD will help more people start conversations with their doctors about the condition. Going ...

Pfizer (NYSE: PFE) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two ...

The U.S. District Court for the District of Columbia on Thursday rejected Teva Pharmaceuticals’ challenge to the Medicare ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

Tens of thousands of American children who begin with a prescription for Attention Deficit Hyperactivity Disorder (ADHD) ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of a comprehensive peer-reviewed narrative review that consolidates pharmacologic, pharmacokinetic and more than a decade of ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing ...

Christoph U. Correll, MD, professor of psychiatry at The Zucker School of Medicine at Hofstra/Northwell and professor and chair of the department of child and adolescent psychiatry at Charité ...